Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Vijay Upreti
Effect of Famotidine on the Pharmacokinetics of Apixaban, an Oral Direct Factor Xa Inhibitor
Clinical Pharmacology: Advances and Applications
Pharmacology
Related publications
Rivaroxaban: An Oral Direct Inhibitor of Factor Xa
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Safety, Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor – In Elderly Chinese Subjects
Thrombosis and Haemostasis
Hematology
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin
Clinical Pharmacokinetics
Pharmacology
Antithrombotic Drug and Its Clinical Indication. Factor Xa Inhibitor. Oral Xa Inhibitor (DX-9065a).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Research and Development Strategy of Antithrombotic Agents: Pharmacology of the Oral Factor Xa-Inhibitor Edoxaban
Folia Pharmacologica Japonica
Pharmacology
Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa Inhibitors
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Fibrin-Targeted Direct Factor Xa Inhibition: Construction and Characterization of a Recombinant Factor Xa Inhibitor Composed of an Anti-Fibrin Single-Chain Antibody and Tick Anticoagulant Peptide
Thrombosis and Haemostasis
Hematology
The Effect of Apixaban on the Pharmacokinetics of Digoxin and Atenolol in Healthy Subjects
Clinical Pharmacology: Advances and Applications
Pharmacology
